(Q34319340)

1 August 2017

1 reference

title

Congenital alpha(2)-plasmin inhibitor deficiencies: a review (English)

1 reference

1 August 2017

0 references

Favier R

1

1 reference

1 August 2017

Aoki N

series ordinal

2

1 reference

1 August 2017

de Moerloose P

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

British Journal of Haematology

1 August 2017

1 reference

1 August 2017

114

1 reference

1 August 2017

4-10

1 reference

1 August 2017

1

1 reference

The alpha2-plasmin inhibitor levels in liver diseases

1 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

The behavior of alpha2-plasmin inhibitor in fibrinolytic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Mannose trimming targets mutant alpha(2)-plasmin inhibitor for degradation by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Identification and Some Properties of a New Fast-Reacting Plasmin Inhibitor in Human Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Organization of the human alpha 2-plasmin inhibitor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Alpha2-plasmin-inhibitor deficiency (Miyasato disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Skeletal changes in congenital fibrinogen abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

The kidney is a major site of alpha(2)-antiplasmin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Restriction fragment length polymorphism caused by a deletion involving Alu sequences within the human alpha 2-plasmin inhibitor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Inhibition of plasminogen binding to fibrin by α2-plasmin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Isolation and Properties of a Low Molecular Weight Antiplasmin of Human Blood Platelets and Serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Assignment of the human alpha 2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2-antiplasmin and in fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02845.X

10.1046/J.1365-2141.2001.02845.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference